Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2017)

Ocular Therapeutix's (OCUL) quarterly Amortizatization of Intangibles came in at $6000.0 in Q2 2017, down 87.76% year-on-year from $49000.0 in Q2 2016, and down 45.45% quarter-over-quarter from $11000.0 in Q1 2017.

Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends

Ocular Therapeutix's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $6000.0 for Q2 2017.

  • On a quarterly basis, Amortizatization of Intangibles fell 87.76% year-over-year to $6000.0 in Q2 2017; TTM through Dec 2017 was $17000.0, a 90.86% decrease from a year earlier, with the FY2017 full-year figure at $17000.0, down 90.86% from the prior year.
  • Amortizatization of Intangibles retreated to $6000.0 in Q2 2017 per OCUL's latest filing, from $11000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $148000.0 in Q3 2015 and bottomed at $6000.0 in Q2 2017.
  • The 3-year median for Amortizatization of Intangibles is $20500.0 (2015), against an average of $48600.0.
  • Across the five-year window, Amortizatization of Intangibles soared 477.78% in 2016 and plunged 89.42% in 2017, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $96000.0 in 2015, then sank by 86.46% to $13000.0 in 2016, then slumped by 53.85% to $6000.0 in 2017.
  • Per Business Quant, the three latest OCUL Amortizatization of Intangibles figures stand at $6000.0 (Q2 2017), $11000.0 (Q1 2017), and $13000.0 (Q4 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Ocular Therapeutix 1.94 Bn 1.94 Bn 9.46 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2017 6,000.00
Jun 30, 2017 6,000.00
Mar 31, 2017 11,000.00
Mar 31, 2017 11,000.00
Dec 31, 2016 13,000.00
Dec 31, 2016 13,000.00
Sep 30, 2016 20,000.00
Sep 30, 2016 20,000.00
Jun 30, 2016 49,000.00
Jun 30, 2016 49,000.00
Mar 31, 2016 104,000.00
Mar 31, 2016 104,000.00
Dec 31, 2015 96,000.00
Dec 31, 2015 96,000.00
Sep 30, 2015 148,000.00
Sep 30, 2015 148,000.00
Jun 30, 2015 21,000.00
Jun 30, 2015 21,000.00
Mar 31, 2015 18,000.00
Mar 31, 2015 18,000.00